Development and Validation of a Prediction Rule for Major Adverse Cardiac and Cerebrovascular Events in High-Risk Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention

References

• Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77.
   PubMed Web of Science ®Google Scholar
• Head SJ, Milojevic M, Daemen J, et al. Stroke rates following surgical versus percutaneous coronary revascularization. J Am Coll Cardiol. 2018;72(4):386–398. doi:10.1016/j.jacc.2018.04.071
   PubMed Web of Science ®Google Scholar
• Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008;371(9628):1915–1920. doi:10.1016/S0140-6736(08)60833-8
   PubMed Web of Science ®Google Scholar
• Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–2619.
   PubMed Web of Science ®Google Scholar
• Kinnaird T, Johnson T, Anderson R, et al. Intravascular imaging and 12-month mortality after unprotected left main stem PCI: an analysis from the British cardiovascular intervention society database. JACC Cardiovasc Interv. 2020;13(3):346–357. doi:10.1016/j.jcin.2019.10.007
   PubMed Web of Science ®Google Scholar
• Kontsevaya AV, Bates K, Schirmer H, et al. Management of patients with acute ST-segment elevation myocardial infarction in Russian hospitals adheres to international guidelines. Open Heart. 2020;7(1):e001134. doi:10.1136/openhrt-2019-001134
   Web of Science ®Google Scholar
• Takeuchi M, Ogita M, Wada H, et al. Comparison of long-term mortality between living alone patients vs. living together patients with acute coronary syndrome treated with percutaneous coronary intervention. Eur Heart J Qual Care Clin Outcomes. 2020;6(4):332–337.
   Web of Science ®Google Scholar
• Mihaylova B, Emberson J, Blackwell L, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581–590.
   PubMed Web of Science ®Google Scholar
• Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188.
   PubMed Web of Science ®Google Scholar
• Kang S-H, Park KH, Ahn H-S, et al. Everolimus-eluting versus sirolimus-eluting coronary stents in patients with and without diabetes mellitus. EuroIntervention. 2014;10(1):74–82. doi:10.4244/EIJV10I1A13
   Web of Science ®Google Scholar
• Brar SS, Kim J, Brar SK, et al. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. J Am Coll Cardiol. 2008;51(23):2220–2227. doi:10.1016/j.jacc.2008.01.063
   PubMed Web of Science ®Google Scholar
• Baber U, Bander J, Karajgikar R, et al. Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thromb Haemost. 2013;110(1):118–123. doi:10.1160/TH13-01-0004
   Web of Science ®Google Scholar
• Baber U, Mehran R, Kirtane AJ, et al. Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the assessment of dual antiplatelet therapy with drug-eluting stents registry. Circ Cardiovasc Interv. 2015;8(6):e001683. doi:10.1161/CIRCINTERVENTIONS.115.001683
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Bernardo E, Capodanno D, et al. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol. 2010;55(11):1139–1146. doi:10.1016/j.jacc.2009.10.043
   PubMed Web of Science ®Google Scholar
• Morrow DA. Cardiovascular risk prediction in patients with stable and unstable coronary heart disease. Circulation. 2010;121(24):2681–2691. doi:10.1161/CIRCULATIONAHA.109.852749
   PubMed Web of Science ®Google Scholar
• Danga GD, Claessen BE, Mehran R, et al. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv. 2012;5(11):1097–1105. doi:10.1016/j.jcin.2012.07.012
   Web of Science ®Google Scholar
• Rao SV, McCoy LA, Spertus JA, et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv. 2013;6(9):897–904. doi:10.1016/j.jcin.2013.04.016
   Web of Science ®Google Scholar
• Mehran R, Baber U, Sharma SK, et al. Ticagrelor with or without aspirin in high-risk patients after PCI. N Engl J Med. 2019;381(21):2032–2042. doi:10.1056/NEJMoa1908419
   PubMed Web of Science ®Google Scholar
• Steg PG, James SK, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–2619. doi:10.1093/eurheartj/ehs215
   PubMed Web of Science ®Google Scholar
• O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;127(4):529–555. doi:10.1161/CIR.0b013e3182742c84
   PubMed Web of Science ®Google Scholar
• Zhang C, Jiang L, Lianjun X, et al. Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease. Eur Heart J. 2019;40(41):3397–3405. doi:10.1093/eurheartj/ehz394
   Web of Science ®Google Scholar
• Tan C, Luo E, Wang D, et al. Usefulness of haemoglobin level combined with CAMI-STEMI score for predicting MACCE in patients with acute ST-elevation myocardial infarction after PCI. Biomed Res Int. 2019;2019(8):1–8.
   Google Scholar
• Doyle BJ, Rihal CS, Gastineau DA, et al. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol. 2009;53:2019–2027.
   PubMed Web of Science ®Google Scholar
• Rao SV, Kaul PR, Liao L, et al. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2008;155(2):369–374. doi:10.1016/j.ahj.2007.10.014
   Web of Science ®Google Scholar
• Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65(2):196–202. doi:10.1002/ccd.20354
   Web of Science ®Google Scholar
• Kirtane AJ, Piazza G, Murphy SA, et al. Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. J Am Coll Cardiol. 2006;47:2374–2379. doi:10.1016/j.jacc.2005.09.080
   PubMed Web of Science ®Google Scholar
• Verheugt FWA, Steinhubl SR, Hamon M, et al. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. J Am Coll Cardiol Intv. 2011;4:191–197. doi:10.1016/j.jcin.2010.10.011
   Web of Science ®Google Scholar
• Rao SV, Ou F-S, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the national cardiovascular data registry. J Am Coll Cardiol Intv. 2008;1:379–386. doi:10.1016/j.jcin.2008.05.007
   Web of Science ®Google Scholar
• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603. doi:10.1161/CIR.0000000000000485
   PubMed Web of Science ®Google Scholar
• Martin JO, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (interstroke): a case-control study. Lancet. 2016;388:761–775. doi:10.1016/S0140-6736(16)30506-2
   Web of Science ®Google Scholar
• Kwok CS, Kontopanteli E, Myint PK, et al. Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007–12. Eur Heart J. 2015;36:1618–1628. doi:10.1093/eurheartj/ehv113
   PubMed Web of Science ®Google Scholar
• Dawson LP, Cole JA, Lancefield TF, et al. Lancefield Incidence and risk factors for stroke following percutaneous coronary intervention. Int J Stroke. 2020;15(8):1–14.
   Web of Science ®Google Scholar
• Bredlau CE, Roubin GS, Leimgruber PP, et al. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation. 1985;72:1044–1052. doi:10.1161/01.CIR.72.5.1044
   PubMed Web of Science ®Google Scholar
• Hoffman SJ, Routledge HC, Lennon RJ, et al. Procedural factors associated with percutaneous coronary intervention-related ischemic stroke.JACC. Cardiovasc Interv. 2012;5:200–206.
   Web of Science ®Google Scholar
• Rapsomaniki E, Shah A, Perel P, et al. Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J. 2014;35(13):844–852. doi:10.1093/eurheartj/eht533
   PubMed Web of Science ®Google Scholar
• Siudak Z, Dziewierz A, Rakowski T, et al. Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry. Catheter Cardiovasc Interv. 2014;83(3):436–442. doi:10.1002/ccd.25169
   PubMed Web of Science ®Google Scholar
• okarek T, Dziewierz A, Plens K, et al. Radial approach expertise and clinical outcomes of percutanous coronary interventions performed using femoral approach. J Clin Med. 2019;8(9):1484. doi:10.3390/jcm8091484
   Web of Science ®Google Scholar
• Tokarek T, Dziewierz A, Plens K, et al. Percutaneous coronary intervention during on- and off-hours in patients with ST-segment elevation myocardial infarction. Hellenic J Cardiol. 2021;62(3):212–218. doi:10.1016/j.hjc.2021.01.011
   PubMed Web of Science ®Google Scholar
• Tokarek T, Dziewierz A, Plens K, et al. Radial approach reduces mortality in patients with ST-segment elevation myocardial infarction and cardiogenic shock. Pol Arch Intern Med. 2021;131(5):421–428.
   Google Scholar
• Dziewierz A, Siudak Z, Tokarek T, et al. Determinants of stroke following percutaneous coronary intervention in acute myocardial infarction (from ORPKI Polish National Registry). Int J Cardiol. 2016;15(223):236–238. doi:10.1016/j.ijcard.2016.08.214
   Web of Science ®Google Scholar
• Yeh RW, Secemsky EA, Kereiakes DJ, et al. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA. 2016;315(16):1735–1749. doi:10.1001/jama.2016.3775
   PubMed Web of Science ®Google Scholar